Clinical Trial Update: Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effects of adding colesevelam HCl, rosiglitazone, and sitagliptin to metformin in adults with type 2 diabetes and hyperlipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Colesevelam (colesevelam)
• Rosiglitazone (rosiglitazone)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes, Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2009-06-17